Scientists Call for Screening Mammography Every Two Years for Most Women

In In The News by Barbara Jacoby

From: UC SAN FRANCISCO Adoption of new guidelines recommending screening mammography every two years for women ages 50 to 74 would result in breast cancer screening that is equally effective, while saving the United States $4.3 billion a year in health care costs, according to a study led by UC San Francisco. The study compares three possible mammography screening strategies …

Researchers study new ways of treating breast cancer

In In The News by Barbara Jacoby

From: authintmail.com Scientists have found that an engineered virus can fight triple negative breast cancer  one of the most aggressive and least treatable forms of the disease. In laboratory experiments involving human cancer cells, scientists used a virus similar to the one that helped eradicate smallpox to coax cancer cells to produce a protein which makes them susceptible to radioactive …

Research team discovers key mechanisms to inhibit triple negative breast cancers

In In The News by Barbara Jacoby

From: healthcanal.com Findings could lead to life-saving treatments to fight tumor metastasis A team of researchers from Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly “triple negative” breast cancers (TNBC). These tumors are extremely difficult to treat, frequently return after remission, and are the most aggressive form of …

Over 70s who think they’re too old to get breast cancer: Elderly women dying needlessly as they are no longer screened

In In The News by Barbara Jacoby

From: dailymail.co.uk Older women may be dying needlessly of breast cancer because they wrongly assume that the threat has passed them by, experts have warned. Figures have revealed that one in three cases of the disease – and more than half of deaths – are in women who are aged 70 or older. Despite this, the age group is not …

Agendia’s MammaPrint & BluePrint Tests for Breast Cancer Highlighted at Personalized Medicine Conference

In In The News by Barbara Jacoby

Molecular subtyping provides a more precise prognosis and valuable guidance about the best treatment for early-stage breast cancer, according to a presentation by Neil Barth, M.D., at the prestigious Personalized Medicine World Conference (PMWC). Dr. Barth, a medical oncologist and Chief Medical Officer of Agendia, was a featured speaker at the recently concluded conference. Agendia’s BluePrint® molecular diagnostics assay is …

Doctors May Need to Revise How They Evaluate Breast Biopsy Results

In In The News by Barbara Jacoby

From: Drugs.com Two types of breast tissue abnormality may have the same potential of progressing to breast cancer, contrary to current belief, according to a new study. One abnormal tissue finding is known as “atypical ductal hyperplasia” (ADH), an accumulation of abnormal cells in a breast duct. The other abnormal finding is “atypical lobular hyperplasia” (ALH), an accumulation of abnormal …

Extended outcomes of adjuvant accelerated partial breast irradiation patients show excellent tumor control, breast cosmesis and minimal late toxicity

In In The News by Barbara Jacoby

From: astro.org Long-term (five-year) outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation (APBI) after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific …

Study examines stem cell role in breast cancer care

In In The News by Barbara Jacoby

By Kaitlin Zurdosky From: michigandaily.com Researchers at the University’s Comprehensive Cancer Center, in collaboration with an international cohort, have developed means of identifying two states of breast cancer stem cells, giving them new clues as to how to treat patients with cancer. By distinguishing the different states, they hope to find more targeted and effective treatments for the disease, which …

Scientists propose a breast cancer drug for bladder cancer patients

In In The News by Barbara Jacoby

From: MedicalXpress.com Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just …

Health Column: Progesterone, the breast cancer shield

In In The News by Barbara Jacoby

by: Scott Rollins, M.D. From: postindependent.com Breast cancer is understandably the greatest concern of women who are considering hormone replacement therapy (HRT), and yet the media and medical community have only confused the issue with blanket statements regarding risk and a sorry lack of specifics. Before deciding whether HRT is right for you, it is essential to learn more about …